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R. Clinton Webb and David F. Bohr 
V ASCULAR tone, a state of maintained contraction of the smooth muscle in the 
vessel wall, is the process by which the blood 
vessel carries out its physiologic functions, its 
pharmacologic responses, and its pathologic 
changes. Current research directed at an under- 
standing of the molecular mechanisms that regu- 
late vascular tone is progressing at a rapid rate. 
The state of this art was surveyed in 1980 by the 
American Physiological Society’s 686-page 
Physiology Handbook, Section 2, Volume II, 
“Vascular Smooth Muscle.” 
The current review should satisfy those who 
have in mind a less extensive compilation of 
information. It also describes new pieces of the 
puzzle that have been found since the Handbook 
went to press over a year ago. 
In the broadest sense, pieces of this puzzle are 
sought to complete two quite different pictures, 
both depicting the affairs of calcium. The first 
deals with the role of calcium in the regulation of 
the contractile proteins; the second with the 
function of cell membranes in the regulation of 
myoplasmic calcium concentration. 
STRUCTURE AND CHEMISTRY OF 
CONTRACTILE ELEMENTS 
Over the past decade, a comfortable concen- 
sus has evolved about the structural components 
involved in the contractile process of smooth 
muscle.‘.’ The components include three types of 
filaments plus dense bodies and attachment 
plaques. When the isolated smooth muscle is 
observed to contract,3 small closely spaced blebs 
are formed on the cell surface, interspersed with 
small undistorted regions. With relaxation, the 
blebs disappear. It is assumed that the undis- 
torted regions are attachment sites for the force- 
generating units to the plasmalemma. The ultra- 
structure demonstrates dense areas on the plas- 
malemma, which are probably attachment sites 
of the filaments. These are the “attachment 
plaques.” Somewhat similar structures called 
“dense bodies” are dispersed throughout the 
sarcoplasm and are believed by some to be intra- 
cellular attachments for contractile filaments. 
Throughout the sarcoplasm, there is a network 
of IO-nm (intermediate) filaments that are 
believed to play a role in the structural or “skele- 
tal” integrity of the cell. These are comprised of 
a 55,000 dalton protein, skeletin. The actual 
contractile apparatus of vascular smooth muscle 
is comprised of thick (14.5 mm) and thin (6.4 
mm) filaments. Strong circumstantial evidence 
supports the hypothesis that force is generated in 
a manner similar to the now classical sliding 
filament model of striated muscle. A schematic 
model of the molecular relationship between the 
thick and thin filaments is shown in Fig. 1.4 In 
this model, neither filament changes length, but 
through a force generated between the two types 
of filaments, they slide by one another in such a 
fashion that the length of the cell tends to 
shorten. 
There are two striking differences between the 
geometric arrangements of filaments in smooth 
muscle as compared to those of striated muscle. 
In the first place, the ratio of the number of thin 
to thick filaments is approximately 15:l in 
smooth muscle, in comparison to 2:l in striated 
muscle. The second difference is in the less well 
regimented arrangement of the thick and thin 
filaments in smooth muscle. When the muscle is 
relaxed, the filaments appear to lie parallel to 
the long axis of the cell. However, when the cell 
shortens, their arrangement tends to become 
progressively more oblique. When the cell has 
shortened maximally, the angle between the axis 
of the cell and the filaments may be as great as 
25-40°.5 The chemistry of the contractile 
proteins to be dealt with in the following para- 
graphs has been extensively reviewed in the 
current literature.‘.436.7 
Myosin 
Each thick filament is comprised of upwards 
of 200 myosin molecules. These are fibrous 
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Fig. 1. Diagram of relationship between myosin and actin. The diagram shows components of three regulatory systems 
for actomyosin ATPase activation. (1) The thin filament regulatory system in which three troponin molecules plus 
tropomyosin act cooperatively in response to en increase in free ionized calcium to permit the activation of the myosin 
ATPase of the globular portion of the myosin molecule by ectin. (2) Actin activation of myosin ATPase by a direct binding of 
calcium to myosin. (3) Phosphorylation of the 20,000 dalton myosin light chain, thereby disinhibiting the actomyosin ATPase. 
Not shown in this diagram is a second thin filament regulating system that involves leiotonin molecules,7 which are bound to 
actin. (Reproduced by permission of Annual Review of Biochemistry.‘) 
structures with globular ends. With appropriate 
enzymatic treatment, the myosin molecule may 
be separated into two parts, heavy and light 
meromyosin. Light meromysin is a fibrous 
protein that lines up in a sheath with other 
similar molecules to form the thick filament. 
Heavy meromyosin makes up the bridge that 
protrudes from the thick filament. In its func- 
tional operation, the myosin molecule behaves as 
if there were a flexible hinge between these two 
components. The fibrous portion of the molecule 
transmits forces generated by the heavy mero- 
myosin. The heavy meromyosin may be further 
fractionated into a fibrous S-2 segment and a 
globular S-l segment (Fig. 1). The latter is the 
operational site of the molecule. It contains the 
attachment site for actin and the enzymatic site 
that hydrolyzes adenosine triphosphate (ATP) 
to release free energy for contraction. Two 
“myosin light chains,” which are components of 
the globular S-l segment, are involved in the 
function of this molecule. Phosphorylation of the 
20,000 dalton light chain, as will be discussed 
later, plays an important role in the initiation of 
the contractile process; the function of the other 
17,000 dalton light chain is not as clearly 
defined. There are distinct differences in chemis- 
try and function between the myosin light chains 
of vascular smooth muscle and those of skeletal 
muscle. 
Actin 
Actin, which is the major component of the 
thin filament, is present in all mammalian cells. 
There is little difference in the chemical compo- 
sition of actin from different sources. Fibrous 
actin, which comprises the thin filament, is 
composed of two strands of 42,000 dalton globu- 
lar actin molecules. Two functional roles of actin 
in the contractile process are: (1) transmission of 
force delivered by the movement of the bridge of 
the myosin molecule, and (2) activation of the 
myosin ATPase to release free energy for 
contraction. 
Tropomyosin 
Tropomyosin, as actin, is a fairly uniform 
molecule in all types of muscle. It has a molecu- 
lar weight of approximately 70,000 daltons and 
is an alpha helix closely attached to the actin 
molecule in the thin filament. Furtheimore, the 
ratio of tropomyosin to actin molecules (approxi- 
mately 1:3) is similar in all types of muscle. The 
major difference between striated and smooth 
muscle with regard to their thin filaments is that 
in striated muscle these contain readily extract- 
able troponin molecules, whereas that of smooth 
muscle does not. There is controversial evidence 
that some regulatory system, such as leitonin, 
may be associated with actin and tropomyosin of 
smooth muscle. 
REGULATION OF VASCULAR TONE, MOLECULAR MECHANISMS 215 
In skeletal muscle, the troponin-tropomyosin 
system is the major protein regulator of contrac- 
tile activity. In the resting muscle, it inhibits the 
activation of myosin ATPase by actin. This inhi- 
bition is nullified by the presence of an adequate 
concentration of free ionized calcium in the 
myoplasm. It now appears that there is no such 
inhibitory action of tropomyosin in smooth 
muscle. Instead, tropomyosin seems to amplify 
the actin-activated ATPase activity of smooth 
muscle.8 
Relations of Myosin and Actin 
The hydrolysis of ATP is the source of energy 
release for muscle contraction. In the intact 
muscle, this ATPase activity is effected by the 
S-l segment of the myosin molecule, which has 
been activated by actin. It is the myosin mole- 
cule, not the actin, that determines the velocity 
of the ATPase activity and hence the energy 
release. Barany’ demonstrated that, in different 
muscles, the maximal shortening velocity is 
directly correlated with the actin-activated 
myosin ATPase activity of that muscle. This 
shortening velocity of vascular smooth muscle is 
approximately 1% as fast as that of fast skeletal 
muscle, reflecting a marked difference in the 
velocity of ATPase activities of these two 
muscles. On the other hand, force-generating 
ability of arterial muscle is, if anything, greater 
than that of skeletal muscle.” Whereas the 
speed of contraction is believed to be a function 
of the actomyosin ATPase activity, and hence of 
the cycling rate of the myosin bridge, the force of 
contraction is considered to be a function of the 
number of simultaneously active force-generat- 
ing relationships between the myosin bridge and 
the thin filament. Both structural and biochemi- 
cal studies have indicated that there is a much 
higher ratio of thin filaments to thick filaments 
in vascular smooth muscle than in skeletal 
muscle ( 15: 1 for vascular smooth muscle and 2: 1 
for skeletal muscle). Although there is less 
myosin in smooth than in skeletal muscle, this 
marked difference in ratio may result in a physi- 
cal arrangement in which a greater number of 
force-generating sites may be active at one time. 
Even among smooth muscles, there are differ- 
ences in the ratio of actin to myosin on a weight 
basis,” whereas the average weight ratio of actin 
to myosin extracted from various arterial 
muscles is 2.6, this ratio for nonarterial muscle is 
1.5. 
The failure of this review to describe the basic 
mechanism by which the relationship between 
myosin and actin results in force generation does 
not reflect a negligence on the part of the review- 
ers. It merely reflects the fact that this informa- 
tion is not available in current literature. 
Regulation of Contractile Protein Activity 
When the membrane structures that govern 
calcium concentration in the myoplasm are 
destroyed by glycerol extraction, the contractile 
activity becomes immediately dependent on the 
presence of calcium in the environment of the 
muscle. In 1964, Filo et aLI2 observed that glyc- 
erol-extracted skeletal muscle and vascular 
smooth muscle had identical calcium dependen- 
cies (see Fig. 2). At that time, the similarity of 
these calcium response curves was interpreted as 
indicating that the molecular mechanisms by 
which calcium-altered contractile protein activ- 
ity was the same in these two types of muscle. 
Evidence developed in the intervening time has 
shown that this conclusion was clearly in error. It 
is now evident that the molecular mechanisms by 
which calcium alters the contractile activity vary 
greatly in different types of muscle. Yet, it is still 
of interest that, in spite of a great variation in the 
evolution of calcium regulatory processes,13 the 
same calcium sensitivity (concentration-re- 
sponse curve) is maintained throughout. 
The mechanisms that regulate contractile 
protein activity are usually assessed by monitor- 
ing the effect of calcium on the ATPase activity 
or on superprecipitation of actomyosin. These 
regulatory mechanisms are shown schematically 
in Fig. 3. They are broadly classified as those 
residing in the thin filament (actin-linked) or in 
the thick filament (myosin-linked) and will be 
described in some detail in the following parts of 
this review. Ebashi and Kodama14 first demon- 
strated a thin filament regulating system in 
mammalian skeletal muscle around 1965, and 5 
yr later, Kendrick-Jones et a1.15 found that 
contraction of the molluscan muscle was regu- 
lated by a thick filament system. It was known 
that crude or native actomyosin from either 
skeletal or molluscan muscle was inactive in the 
absence of calcium but could be activated by the 
addition of calcium. Ebashi observed that in the 
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Fig. 2. Effects of concentrations of free calcium on tension development by glycerinated psoas (striated) and vascular 
smooth muscle fibers. Conditions: temperature, 20°C; KCI. 160 mM; histidine buffer (pH 6.6). 20 mM; ATP and magnesium. 5 
mM: EGTA, 4 mM. Free calcium concentration wes varied by changing the ratio of calcium to EGTA. Calcium requirements for 
contraction of these two preparations are virtually identical. (Reproduced by permission of Science.‘*) 
absence of calcium, when pure actin was added 
to the native actomyosin of skeletal muscle, this 
otherwise inactive preparation became activated. 
However, pure myosin, which had failed to acti- 
vate native actomyosin from skeletal muscle, was 
found to be effective in activating native acto- 
myosin from molluscan muscle. This techniqueI 
has been used extensively to determine whether 
the regulating system of various types of acto- 
myosin resided in the thin (actin) or thick (myo- 
sin) filament. The principle of this technique is 
presented in Table 1. 
Regulation by Troponin and Tropomyosin 
(Fig. 3, no. I) 
Development of insight into thin filament 
regulatory system was slow and fraught with 
controversy. Although Heilbrunn” and Kamada 
and Kinoshita” established during the 1940s 
that calcium was clearly involved in excitation- 
contraction coupling, the mechanism by which it 
produced activation remained unclear during the 
1950s when the Marsh-Bendall relaxing factor” 
dominated the attention of investigators inter- 
ested in this process. Furthermore, even in the 
early 196Os, the preeminent role of calcium as a 
coupler was questioned because, although it was 
effective on crude systems such as glycerinated 
fibers or native actomyosin, it was not necessary 
for the activation of reconstituted actomyosin 
that was prepared by combining preparations of 
pure actin and pure myosin. It was argued that if 
calcium was not necessary to activate the pure 
system, it was probably not the primary factor 
involved in activating the contractile proteins in 
situ. In the mid 1960s Ebashi and his collabora- 
tors14 discovered that the missing link in this 
system was the troponin-tropomyosin system. In 
the intact resting muscle and in the extract of 
crude actomyosin, the ATPase activity of acto- 
myosin is normally inhibited by a complex coop- 
erative influence of troponin and tropomyosin. 
This inhibitory action of the troponin-tropomyo- 
sin system is eliminated when calcium combines 
Table 1. Technique for Determining Whether a Muscle is 
Actin- or Myosin-Regulated 
Calcium 
Evidence for actin regulation 
Yes + native AM 
No native AM 
No native AM + pure A 
NO native AM + pure M 
Evidence for myosin regulation 
Yes + native AM 
No native AM 
NO native AM + pure A 
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Fig. 3. Thin and thick filament regulatory systems for muscle contraction. Each system is turned on through a quite 
different calcium-sensitive regulatory mechanism. All require the same concentration of activator calcium. Each system is 
discussed in the text and described in detail in the following references: lsr; 2’; 3”; 4.“’ The following symbols are used: T. 
tropomyosin: Tn. troponin. Three component troponin molecules are designated Tn, associated with tropomyosin: Tn, 
calcium binding; and Tn, ATPase inhibitory component. The heavy “X” across an arrow indicates that the process is blocked. 
with one of the troponins, TN-C. The binding of 
calcium to TN-C has the same calcium concen- 
tration dependence as does the activation of 
crude actomyosin ATPase. The action of 
calcium is therefore not a direct activation, but 
instead a disinhibition of the troponin-tropo- 
myosin system. Because troponin and tropomyo- 
sin are bound to actin in the thin filament, both 
in situ and when extracted in the native state, 
this regulatory system has been referred to as the 
actin-linked or thin filament regulatory system. 
It is well established as the regulatory system for 
contraction of mammalian skeletal and cardiac 
muscle. 
Regulation by Direct Action of Calcium on the 
Myosin Light Chain (Fig. 3, no. 4) 
The myosin-linked regulatory system of the 
molluscan muscle resides in myosin light chains. 
The light chains can be removed from the 
myosin molecule by treatment of these compo- 
nents with 10 mM EGTA.“.” In the absence of 
these light chains, the myosin from molluscan 
muscle can be activated by actin in the absence 
of calcium. From this observation it has been 
inferred that these light chains normally inhibit 
actin activation and that this inhibition is 
removed by the presence of calcium. When the 
20,000 dalton light chain from molluscan or 
smooth muscle is added back to this system, its 
calcium requirement for activation is restored. 
Myosin light chain from mammalian skeletal or 
cardiac muscle myosin is not capable of restoring 
calcium dependence to molluscan myosin.” The 
regulation of ATPase activity in the molluscan 
muscle is not altered by phosphorylation of the 
myosin light chains.22 
Regulation of Phosphorylation of Myosin Light 
Chain (Fig. 3, no. 3) 
In contrast to the myosin-linked regulatory 
system of molluscan muscle, that of mammalian 
smooth muscle, also myosin-linked, appears to 
be regulated primarily by phosphorylation of the 
20,000 dalton myosin light chain. This conclu- 
sion has been documented by several types of 
observations. In Fig. 4, DiSalvo et al.23 demon- 
strate that this phosphorylation parallels the 
actomyosin ATPase activity over the relevant 
range of the calcium concentrations. They also 
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Fig. 4. Calcium dependence of myosin light chain phos- 
phorylation and of actomyosin ATPase activity of bovine 
aorta. Values are given for three different preparations 
identified by different symbols. The extent of phosphoryla- 
tion is expressed as the ratio of the peak area of the 
phosphorylated polypeptide to the sum of the parent 
nonphosphorylated band plus the phosphorylated band. 
(Reproduced by permission of Proceedings of the Society 
for Experimental Biology and Medicine.w) 
observed that phosphorylation of the light chain 
precedes ATPase activity, as 50% of the maxi- 
mal phosphorylation occurred in only 30 set 
incubation, at which time virtually no inorganic 
phosphate had been released from ATP by acto- 
myosin. This suggests that the phosphorylation 
occurs before the ATP can be hydrolyzed. It is 
the heavier light chain (20,000 dalton) that is 
phosphorylated in the presence of the calcium 
(see Fig. 5). Evidence that it is phosphorylation 
per se rather than the free calcium concentration 
that activates the ATPase has been presented by 
Small and Sobieszek.’ They observed that the 
rate of inorganic phosphate liberation from ATP 
is not altered when free calcium in the solution is 
chelated by EGTA (see Fig. 6.). 
The relationship between phosphorylation and 
activation of the contractile system of vascular 
smooth muscle has been demonstrated not only 
for actomyosin ATPase activity, but also for 
superprecipitation and for the contraction of 
intact living smooth muscle cells.*’ Dillon et al.*’ 
used a quick-freeze technique to study phospho- 
rylation in isolated but intact swine carotid 
arteries. They observed that the extent of the 
phosphorylation of the light chain paralleled the 
Fig. 5. Incorporation of =P from ATP in different 
regions of SDS gel. Striped bars show the extent of =P 
incorporation in the presence of lo-‘M Cat+; whereas the 
solid bars show incorporation in the presence of 1 mM 
EGTA. Major bands are identified M hnyosinj, AC factin), 
Tm ftropomyosinj, L, (larger light chain), L2 (smaller light 
chain). The phosphorylation of the larger light chain under 
the influence of the calcium is evident in the tall crosshatch 
bar. (Reproduced by permission of proceedings of the 
Society for Experimental Biology and Medicine.“) 
active state of the contractile process of this 
muscle. 
Further insight has been given into the regula- 
tory role played by the myosin light chain by 
storing native actomyosin from vascular smooth 
muscle at 4°C.24*26 This cold storage is associated 
with a progressive loss of the phosphorylatable 
light chain. With the loss of this light chain, 
calcium is no longer required for actomyosin 
ATPase activity or for superprecipitation. These 
observations suggest that in the fresh native 
actomyosin the unphosphorylated light chain 
plays an inhibitory role on the ability of actin to 
stimulate actomyosin ATPase. Physiologically, 
in the living tissue, this inhibition is prevented 
when the light chain is phosphorylated by the 
calcium-dependent myosin light chain kinase. 
When the myosin light chain is lost after 5 days 
of cold storage, the inhibiting effect of this 
protein is also lost, and the actomyosin ATPase 
is active in the absence of calcium. 
The myosin light chain kinase that effects this 
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the presence of a cardiac protein kinase, which 
phosphorylates the myosin light chain kinase. 
When protein kinase was stimulated by 2 mM 
cyclic AMP, phosphorylation of the myosin light 
chain was reduced by approximately 50%. 
Obviously, cyclic AMP does not have a stimulat- 
ing effect on myosin light chain kinase. Since the 
magnitude of actomyosin activation is a direct 
function of myosin light chain phosphorylation, 
the reduction in its phosphorylation produced by 
this cyclic nucleotide may have an important 
modulating effect on contraction. In Fig. 7, 
Adelstein and Eisenberg4 depict a cascade of 
events utilizing this system, beginning with the 
increase in cyclic AMP resulting from /3-adren- 
ergic activation and ending with smooth muscle 
relaxation. Hoar et a1.30 have shown that in the 
chemically skinned smooth muscle fiber, the 
addition of cyclic-AMP-dependent protein ki- 
nase plus cyclic AMP resulted in a decrease in 
smooth muscle tension. Silver and DiSalvo3’ 
have observed that bovine coronary arteries 
made to contract by stimulation with KC1 were 
relaxed in a dose-dependent fashion by addition 
of isoproterenol to the bath. The magnitude of 
relaxation was paralleled by an increase in the 
activity of tissue protein kinase. Adenosine may 
produce relaxation by a similar mechanism.32 
Fig. 6. Effect of Caf+ removal on ATPase activity of 
phosphorylated actomyosin. Closed circles show inorganic 
phosphate liberation from 0 to 60 set in the presence of 
2 x lo-’ M calcium. Squares show an experiment carried 
out under the same condition except that excess EGTA 
(2 mM) was added after 40 set of incubation. Open circles 
show a controlled experiment for which the same amount 
of EGTA was added prior to the initiation of the study by 
the addition of ATP. As shown, the removal of calcium 
after 40 set did not affect the rate of ATP hydrolysis. Other 
measurements show that the extent of myosin phospho- 
rylation was unchanged following the addition of EGTA. It 
was concluded that ATPase was not directly dependent on 
the presence of free Ca++ but that it does require the 
presence of a phosphorylated myosin light chain. (Repro- 
duced by permission of International Review of Cytology.‘) 
phosphorylation is a specific calcium-requiring 
enzyme.4 It has a molecular weight of approxi- 
mately 130,000 daltons and is activated by 
calmodulin (16,500 daltons). Calmodulin is 
present in all tissues, but the kinase that it 
activates is specific for smooth muscle. The 
larger molecule must be activated by calmodulin 
before it can phosphorylate the light chain, and 
calmodulin requires a concentration of calcium 
greater than 10e7 before it can activate the 
kinase. Recently it has been observed that 5pM 
exogenous calmodulin increased the speed of 
tension development of skinned smooth muscle, 
by tenfold but had no effect on this variable 
when skeletal muscle was used.27 
Conti and Adelstein28 have observed that 
when myosin light chain kinase is itself phospho- 
rylated, the affinity of the myosin kinase for 
calmodulin is decreased. This should and does 
result in a decrease in myosin kinase activity. 
Silver and DiSalvo29 have observed an approxi- 
mately 10% decrease in phosphorylation of 
myosin light chain from aortic smooth muscle in 
Myosin light chain kinase is dephosphorylated 
by a specific phosphatase found in smooth 
muscle and in other tissue.34 Action of these 
phosphatases lower the actin-activated ATPase 
activity of phosphorylated myosin. This phos- 
phorylase can also dephosphorylate myosin light 
chain kinase. Activity of the phosphorylase plays 
an obvious role in vascular smooth muscle relax- 
ation, but factors that may influence the activity 
of the phosphatases are not understood. This is 
potentially a second site for modulating the regu- 
latory system for vascular smooth muscle. 
Dillon et a1.25 have recently made observations 
that implicate phosphatase and myosin light 
chain dephosphorylation in a mechanical process 
of the contractile protein of vascular smooth 
muscle that may be responsible for the high 
economy of force maintenance in the blood 
vessel wall.3s Their study of the mechanical 
response of smooth muscle in strips of pig carotid 
artery stimulated with KC1 is illustrated in Fig. 
8. Following stimulation, load-bearing capacity 
gradually reached a maximum in about 5 min 
and was maintained thereafter. Using a measure 
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Fig. 7. Regulation of smooth muscle contraction by Ca’+ and CAMP. Ca”+: Calcium, at a concentration of lo-‘M, binds to 
calmodulin, and the Ca*+ -calmodulin complex binds to the inactive form of myosin kinase. The active kinase catalyzes 
phosphorylation of the myosin light chain, which results in a form of myosin that can interact with actin, causing smooth 
muscle contraction. A decrease in the Ca’+ concentration to 1 O-’ M leads to a dissociation of calcium and calmodulin from the 
active kinase, which results in an inactive form of the kinase. Under these conditions, myosin phosphatase, which is not 
dependent on Cazf for activity, dephosphorylates myosin, causing smooth muscle relaxation. CAMP: Stimulation of the 
beta-receptor by epinephrine results in an increase in adenylate cyclase activity and hence an increase in cyclic AMP 
production. This results in an active form of protein kinase (Cl. Phosphorylation of the myosin kinase by protein kinase 
weakens the binding of Ca” -calmodulin to the myosin kinase, and hence favors the inactive form of the myosin kinase. 
Dephosphorylation of the myosin kinese by phosphatase restores the kinase to the form that binds Ca’+-calmodulin strongly. 
The length of the arrows between the inactive and active forms of myosin kinase qualitatively indicates the direction in which 
the equilibrium is shifted. Inactivation of myosin kinase by phosphorylation favors the dephosphorylated form of myosin and 
results in smooth muscle relaxation. This may explain how epinephrine acts to relax certain smooth muscles. I?, regulatory 
subunit of CAMP-dependent protein kinase: C, catalytic subunit of CAMP-dependent protein kinese. (Reproduced by 
permission of Annual Review of 6iochemistry.‘~ 
of ~ltlax obtained from force-velocity relation- 
ships, these investigators were able to estimate 
cross-bridge cycling rates. In response to this 
stimulation with KCl, the V,,, peaked in 30 set, 
then fell off, reaching a constant low value after 
5 min. Measurement of the ratio of phosphory- 
lated to dephosphorylated myosin light chain 
indicated that this ratio followed the V,,, rather 
than the load-bearing capacity of the muscle. 
Thus, it appears that the light chain was dephos- 
phorylated by a phosphatase, and that dephos- 
phorylated cross-bridges remain attached, main- 
taining the load-bearing capacity, but were 
noncycling, conserving ATP. The investigators 
called these “high economy” load-bearing 
connections “latch-bridges.” 
Regulation by Leiotonin on the Thin Filament 
(Fig. 3, no. 2) 
As convincing as these arguments seem in 
support of myosin light chain phosphorylation as 
the regulator of vascular smooth muscle contrac- 
tion, there is at least one well documented alter- 
native. Ebashi and coworkers, in 1975,36 discov- 
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Fig. 8. Mechanical and chemical correlates in response 
to stimulation of smooth muscle from the pig carotid with 
potassium. The load-bearing capacity (solid circles), short- 
ening velocity at an afterload of 0.12 F, (solid squares), and 
fractional phosphorylation of myosin light chain (open 
circles) are plotted as a function of time after the potas- 
sium stimulation on a log scale. The mechanical data are 
averages of five different tissues. Each phosphorylation 
determination represents a single tissue, frozen at the 
indicated time fn = 30). The velocity of shortening, which is 
an index of myosin bridge cycling rate and the light chain 
phosphorylation, follow parallel activity patterns that 
subside 5 min after stimulation, while the load-bearing 
capacity remains high. (Reproduced by permission of 
Science.2s) 
ered an 80,000 dalton protein component of 
native actomyosin from chicken gizzard. In 
1977,37 they reported that this protein, which 
they called leiotonin, was essential for activation 
of actomyosin in the presence of calcium. It 
differed from troponin in that its affinity for 
actin was greater than for tropomyosin. 
Nevertheless, tropomyosin is also essential for 
full activation of ATPase activity and superpre- 
cipitation of actomyosin by leiotonin. These 
investigators reported another difference from 
skeletal muscle regulation; they demonstrated 
that pure actin and myosin from chicken gizzard 
did not have ATPase activity, even in the 
presence of calcium, unless the regulatory 
proteins, tropomyosin and leiotonin, were pres- 
ent. Evidence in support of this difference is 
shown in Fig. 9. Smooth muscle contractile 
protein is activated only in the presence of the 
regulatory proteins and calcium, whereas skele- 
tal muscle is activated in the absence of regula- 
tory proteins and calcium but depressed by the 
presence of regulatory proteins without calcium; 
this depression is overcome in the presence of 
calcium. 













Fig. 9. Actomyosin ATPsse activity of reconstituted 
actomyosin of rabbit skeletal (open bars) and chicken 
gizzard (hatched bars) muscles. The regulatory protein for 
skeletal muscle is a complex of almost pure troponin and 
tropomyosin; that from gizzard was a crude mixture 
containing leiotonin and tropomyosin. The skeletal muscle 
shows almost full ATPase activity in the absence of regule- 
tory proteins whether or not calcium ion is present. In 
contrast, that from the gixxard remains in a depressed 
state in the absence of regulatory proteins, suggesting that 
the latter are necessary for activation of the ATPase 
activity. (Reproduced by permission of the Proceedings of 
the Royal Society of London.03) 
leiotonin A, the relatively high molecular weight, 
80,000 dalton, protein and (2) leiotonin C, a 
17,000 dalton protein. Leiotonin C is a calcium 
binding protein, which, although clearly dif- 
ferent from calmodulin, can be substituted by 
calmodulin in support of activation of actomyo- 
sin ATPase by leitonin A.’ One problem that 
must be reconciled in supporting the leiotonin 
mechanism for actomyosin regulation relates to 
the stoichiometry of the proteins. There is only 
one leiotonin molecule for every 10 tropomyosin 
molecules and one tropomyosin molecule for 
each of 3+ actin molecules. It is difficult to 
conceive of a system where one leiotonin mole- 
cule would have such a broad regulatory 
influence. 
Ebashi has concluded that in gizzard smooth 
muscle the calcium-sensitive process is in the 
thin filament, though the mechanism and the 
working of the component parts remain to be 
explained. A similar leiotonin regulator system 
has been described for bovine aortic smooth 
muscle.4 Not only have Ebashi and coworkers’ 
found this thin-filament-related regulatory sys- 
tem in smooth muscle, but they have also 
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presented the following evidence that argues 
against the importance of the myosin light chain 
phosphorylation mechanism for actomyosin reg- 
ulation. (1) Whereas leiotonin fully activated the 
ATPase activity of a mixture of myosin, actin, 
and tropomyosin in the presence of calcium, it 
phosphorylated myosin only weakly. In contrast, 
the combination of the myosin light chain kinase 
and calmodulin fully phosphorylated the myosin, 
but only weakly activated the ATPase. (2) When 
phosphatase was added to native actomyosin, 
superprecipitation occurred in the presence of 
calcium, despite the lack of phosphorylation of 
the myosin light chain. (3) Phosphorylation of 
this system was very weak at pH 6.7, despite a 
full activation of the ATPase. 
Strong, even outspoken defense may be found 
in support of each of the proposed regulatory 
mechanisms. Bearing on the difference in find- 
ings on this subject, Nonomura and Ebashi7 
state that their results “suggest that careful 
experimental planning is indispensable for physi- 
ologic experiments to overcome any tendency to 
arrive at superficial understanding.” Small and 
Sobieszek’ deal with results in support of leio- 
tonin by concluding that “much of their 
evidence, however, may be explained in terms of 
a contamination of the different preparations 
with light chain kinase and possibly also the 
activator protein that confers calcium sensitivity 
to the kinase.” 
In view of the current state of the art, both 
systems must be considered as potentially valid 
because of both the preeminence of the investi- 
gators in each camp and the possibility that 
smooth muscle may have a dual regulatory 
system involving both thick and thin filaments. 
Marston et a1.38 have recently studied the 
calcium regulatory system of pig aorta and of 
turkey gizzard smooth muscle actomyosin using 
myosin and actin competition tests. They have 
concluded from these and from more detailed 
studies of the regulatory systems that smooth 
muscle has both thin filament and myosin-linked 
calcium regulatory systems. 
CELLULAR SITES FOR THE REGULATION OF 
INTRACELLULAR CALCIUM 
There is little question that the interaction of 
the contractile proteins responsible for contrac- 
tion and relaxation is regulated by the intracellu- 
lar concentration of ionized calcium. The identi- 
tication of the anatomical structures responsible 
for the raising and lowering of ionized calcium 
remains a major objective in vascular smooth 
muscle research. In striated muscles, the sarco- 
plasmic reticulum is the intracellular structure 
that accumulates calcium during relaxation and 
from which the calcium that activates contrac- 
tion is released by the action potential. In vascu- 
lar smooth muscle, the following structures have 
been implicated in this function: (1) cell 
membrane, (2) sarcoplasmic reticulum, and (3) 
mitochondria. 
Cell Membrane 
The plasma membrane is an important barrier 
to calcium entry and it contains regulatory 
devices that function in the maintenance of 
intracellular calcium levels. Additionally, the 
plasma membrane plays an important role in 
cell-to-cell communication of ionic and meta- 
bolic information via cell junctions.* 
Ultrastructural observations indicate that the 
cell membrane is about 7-10 nm thick and is 
composed, as in most other tissues, of three 
layers (2 osmiophillic layers, 2.5 nm thick, sepa- 
rated by a dense layer, 3 nm thick). The cell 
membrane of vascular smooth muscle is invagi- 
nated to form surface vesicles or caveolae (50-80 
nm in diameter). Devine et a1.39 have shown that 
colloidal lanthanum, an extracellular marker, 
enters the surface vesicles, and therefore, these 
vesicles are in direct communication with the 
extracellular space. These flask-like structures 
increase the effective surface area of the 
membrane by 25%-75%. Conventional electron 
microscopic techniques,40*4’ as well as freeze- 
fracture studies,42 show that the surface vesicles 
form a linear array along the longitudinal axis of 
the smooth muscle cell. Although the vesicles are 
found on all surfaces of the cell membrane, they 
are more numerous on the outer (towards adven- 
tia) and interfaces of muscle ceils than on the 
inner (towards lumen) surfaces.4345 Recent 
observations of membrane systems in mouse 
coronary arteries indicate that vesicles may 
occur singly or in more complex forms that 
resemble chains of beads fused end-to-end.45 
These beaded tubules may be composed of as 
many as 17 vesicles and often extend deep into 
the cell (Fig. 10). Branched arrays of intercon- 
nected vesicles were also observed. The number 
of vesicles in the membrane are dependent on the 
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Fig. 10. Surface vesicles in smooth muscle cells of mouse coronary artery, The surface vesicles in vascular smooth 
muscle may occur in complex forms that resemble elongated beaded tubules. This particular example is composed of 
approximately 17 vesicles fused end-to-end. The arrow indicates the ostium of the beaded tubules. The magnification in this 
electron micrograph is 134,500 x . (Reproduced by permission of Journal of Ultrastructural Resear~h.~) 
age of the animal; vascular tissue from older 
animals have many more vesicles than that from 
younger animals.46 Unlike vertebrate vascular 
smooth muscle, the surface vesicles of the aorta 
and vena cava of the diamondback turtle have 
parallel striations or shelves within the vesicular 
membrane.47 
The surface vesicles are believed to be analo- 
gous to the transverse tubules (T tubules) of 
striated muscles. Thus, they have been proposed 
to play a role in ion transfer between intracellu- 
lar structures, such as the sarcoplasmic reticu- 
lum and mitochondria. Although actual transfer 
of ions has not been demonstrated, a close struc- 
tural association between the membranes of the 
sarcoplasmic reticulum and mitochondria and 
those of the surface vesicles is often observed in 
electron micrographs of vascular smooth mus- 
cle.2,39*45 The sarcoplasmic reticulum surface 
vesicle contacts are called “couplings” and are 
bridged by small electron-dense structures. 
These couplings may be sites at which calcium is 
released during the action potential, as in 
cardiac muscle (Fig. 1 1). 
The surface membrane adjacent to the vesi- 
cles has also been proposed to play a role in ion 
transfer. Freeze-fracture studies42,48 reveal that 
these regions of the cell membrane contain a 
high density of membrane particles on the cyto- 
plasmic membrane leaflet as compared to the 
external leaflet. There is an absence of these 
particles on the actual vesicle.49 The particles are 
thought to be membrane proteins important for 
ion binding and pumping. 
Sarcoplasmic Reticulum 
The sarcoplasmic reticulum in vascular 
smooth muscle, as in striated muscle, is believed 
to fulfill some function in the storage, uptake, 
and release of calcium. The use of extracellular 
markers (ferritin, horseradish peroxidase, and 
colloidal lanthanum) has demonstrated that the 
sarcoplasmic reticulum is a true intracellular 
membrane system, rather than a system of 
tubules communicating with the extracellular 
space. 39V47*50 The smooth tubules of the sarcoplas- 
mic reticulum are continuous with the rough 
endoplasmic reticulum and with the nuclear 
membrane. The form and distribution of this 
membrane system is best demonstrated in vascu- 
lar tissues postfixed in osmium-ferrocyanide 
after initial fixation in an aldehyde solution 
containing 5.0 mM CaC1,.45,5’ Using this tech- 
nique, the membranes of the sarcoplasmic reti- 
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Fig. 11. Structural association between surface vesi- 
cles and sarcoplasmic reticulum. This electron micrograph 
illustrates the close anatomical association between the 
membranes of the sarcoplasmic reticulum (SRI and those 
of the surface vesicles EW in a smooth muscle cell of the 
rabbit main pulmonary artery. Four portions of the sarco- 
plasmic reticulum approach membranes associated with 
surface vesicles. Dense bodies (DE) alternate with periph- 
eral sarcoplasmic reticulum membranes and surface vesi- 
cles. The arrows indicate microtubules and the upper cese 
“M” indicates a mitochondrian. (Reproduced by permission 
of Journal of Call Biology.? 
culum and the nuclear envelope become 
intensely opaque, whereas the membranes mak- 
ing up the Golgi apparatus do not. 
Quantification of the volume of sarcoplasmic 
reticulum within the smooth muscle cell has 
been performed by the use of tilt-stage electron 
microscopy and integration by weight of result- 
ing montages.39 Tonic smooth muscles (rabbit 
main pulmonary artery and aorta), which do not 
spontaneously generate action potentials and 
respond to excitatory agents by graded depolari- 
zation, contain from 5% to 7.5% sarcoplasmic 
reticulum (nucleus and mitochondria-free cell 
volume), whereas phasic smooth muscles (rabbit 
portal-anterior mesenteric vein) contain from 
2% to 3% sarcoplasmic reticulum. It has been 
observed that smooth muscles that contain a 
large volume of sarcoplasmic reticulum have the 
ability to maintain contractions in the absence of 
calcium, whereas smooth muscles with less 
sarcoplasmic reticulum do not. 
The possibility that the sarcoplasmic reticu- 
lum may be a functional source of activator 
calcium in vascular smooth muscle is suggested 
by electron microscopic studies employing elec- 
tron-opaque divalent cations (e.g., strontium) 
that may substitute for calcium. Vascular tissues 
incubated in strontium-containing solutions have 
electron-opaque deposits in the sarcoplasmic 
reticulum that have been identified as strontium 
by electron probe analysis.52,53 Recently, electron 
probe analysis of unfixed, frozen, dried thin 
sections has localized calcium to the sarcoplas- 
mic reticulum of vascular smooth muscle.‘* 
Cytochemical studies, using pyroantimonote or 
oxalate to localize calcium, have also demon- 
strated granules (presumably, calcium pyroanti- 
monote and calcium oxalate, respectively) asso- 
ciated with sarcoplasmic reticulum of rat and pig 
pulmonary artery,” rat aorta,56 and pig coronary 
artery.” 
Mitochondria 
The mitochondria may also serve as a store of 
calcium in vascular smooth muscle. As in other 
tissues, these cigar-shaped organelles in vascular 
smooth muscle are bound by a double 
membrane and contain prominent cristae.46 The 
mitochondria are often closely associated with 
the surface vesicles (4-5 nm between the mito- 
chondrial and vesicular membrane).39”3*58 Incu- 
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bation of vascular smooth muscle in strontium- 
or barium-containing solutions produces visual- 
ization of intramitochondrial electron-opaque 
granules.s2~s3~59 Electron probe analysis indicates 
that these granules exhibit energy peaks charac- 
teristic of strontium and barium, respec- 
tively.52,60 A very large energy peak correspond- 
ing to calcium has also been observed in mito- 
chondria of vascular smooth muscle using elec- 
tron probe analysis.@’ 
MEMBRANE ELECTRICAL EVENTS 
The intracellular level of activator calcium in 
vascular smooth muscle is influenced by the 
electrical state of the cell membrane. Changes in 
the membrane potential and generation of action 
potentials constitute the electrical events that 
influence contractile responses of vascular 
smooth muscle. 
Membrane Potential 
The resting membrane potential of vascular 
smooth muscle as measured by intracellular 
microelectrode techniques ranges from -40 to 
-75 mV.6’ Two major cellular processes are 
considered to be responsible for this transmem- 
brane potential difference: (1) an unequal distri- 
bution of major ions associated with differing 
membrane permeabilities to the respective ions; 
and (2) an electrogenic transport of ions. The 
former membrane process results in the genera- 
tion of a diffusion potential; whereas the latter 
process results in a separation of electrical 
charge due to unequal stoichiometric exchange. 
Both membrane processes are important deter- 
minants of the resting membrane potential, and 
therefore both affect the contractile properties of 
the vascular smooth muscle cells. 
Analysis of monovalent ion fluxes and 
measurement of membrane potential by electro- 
physiologic techniques have been important 
methods to study the processes involved in the 
contribution of passive membrane permeability 
to vascular responsiveness. For example, Kreye 
and coworkers62.63 have observed that the passive 
permeability of radioactive chloride ions is 
increased by norepinephrine, and nitroprusside 
or nitroglycerin reduce the magnitude of this 
norepinephrine-induced increase. They postu- 
lated that the relaxing effect of nitroprusside and 
nitroglycerin is due to a membrane hyperpolari- 
zation effected by a reduction in membrane 
permeability to chloride ion resulting in a buiid- 
up of negative charge within the cell. Harder and 
Coulsen64 observed that diethystibesterol hyper- 
polarized dog coronary arteries from - 5 1 mV to 
-64 mV and input resistance decreased from 10 
megohms to 5 megohms. They suggested that 
membrane hyperpolarization in response to this 
drug was due to a mechanism that increases 
potassium conductance. Graded increases in the 
concentration of extracellular potassium ion 
cause depolarization of vascular smooth mus- 
cle.65 
A reduction in the extracellular concentration 
of potassium below physiologic levels also causes 
depolarization of vascular smooth muscle.65 This 
membrane depolarization is the result of a 
decrease in the activity of an electrogenic sodium 
pump that normally contributes to the resting 
membrane potential.66 The net effect of this 
pump is to extrude sodium ions against an elec- 
trochemical gradient and to take up potassium 
ions against a diffusion gradient but down its 
electrical gradient. This active transfer of ions is 
driven by the hydrolysis of adenosine triphos- 
phate (ATP). Based on the analysis of ouabain- 
sensitive ion movements, the stoichiometry of the 
reaction is believed to be three sodium ions 
moved out of the cell in exchange for two potas- 
sium ions pumped in per molecule of ATP 
hydrolyzed.67 Thus, the pump is electrogenic, 
since a net excess of positive charge is moved out 
of the cell. 
Sodium-potassium adenosine triphosphatase 
(ATPase) is the enzyme that provides the mech- 
anism for the electrogenic pumping of sodium 
and potassium.68,69 Quantitative estimates of the 
activity of this enzyme have been difficult 
because the structural complexity and size of the 
vessel wall have limited the application of 
conventional biochemical techniques. 
Classically, the activity of any ATPase is 
measured as the amount of inorganic phosphate 
liberated from the hydrolysis of ATP. Experi- 
mental conditions then define the sensitivity of 
the enzyme to sodium and potassium and the 
dependence of its activity upon specific interven- 
tions. Until recently, there has been very little 
application of biochemical principles to the 
study of sodium-potassium ATPase in vascular 
smooth muscle. 
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Table 2. Sodium-Potassium ATPase Activity in Vascular Smooth Muscle 
Species and 
Type of Blood Vessel 




Rat cerebral microvessels 
Bovine aorta 
Dog mesanteric arteries 
Sheep carotid artery 
Bovine carotid artery 
Rabbit aorta 
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2 (calculated from reported 
observations) 
Reference 
Allen and Seidel” 
Allen and Se&IT3 
Allen et al.” 
Bonting et al.7o 
Eisenberg and Suddith’4 
Hess and Ford76 
Limas and Cohn76 
Preiss and Banaschak”.” 
Preiss and Banaschak79 
Verity and Bevan7’ 
Wei et al.8o 
Wolowyk et al.” 
In 1961, Bonting et al.” reported that tissue 
homogenates of cat aorta contained Na-K 
ATPase activity that was ouabain sensitive (see 
Table 2). The Na-K ATPase activity was 
approximately 30% of the total magnesium- 
dependent ATPase activity. Eight years later, 
Verity and Bevan” prepared subcellular frac- 
tions by differential centrifugation of homoge- 
nates of rabbit aorta. Most of the magnesium- 
dependent ATPase activity was found in the 
microsomal fraction (102,000 g). However, 
these investigators were unable to demonstrate 
stimulation of the enzyme with sodium and 
potassium and inhibition of the activity with 
ouabain in this preparation. During the 197Os, 
many investigators’*-*’ demonstrated Na-K 
ATPase activity in a variety of blood vessel types 
from several different animal species. The activi- 
ties of the enzyme in these different membrane 
preparations show considerable variability (Ta- 
ble 2). Although it is certain that differences in 
enzyme activity exist at different levels of the 
circulation and in different animal species, a 
portion of the variability is probably due to the 
development of adequate preparative techniques. 
Alternative methods for estimation of electro- 
genie transport have therefore played an impor- 
tant role in the evaluation of Na-K ATPase in 
vascular smooth muscle. These alternative meth- 
ods are: (1) potassium-induced relaxation; 
(2) membrane potential; and (3) ion flux 
measurement. Useful information about pump 
activity has been generated using these tech- 
niques. 
Potassium-Induced Relaxation 
Vascular smooth muscle, made to contract in 
response to norepinephrine in a potassium-free 
solution, relaxes when potassium is returned to 
the bathing solution (Fig. 12). The magnitude of 
this relaxation is a functional measure of the 
electrogenic pumping of sodium and potassium 
by sodium-potassium ATPase. During the incu- 
bation in potassium-free solution, the activity of 
Reloxotion = 74.2 % 
$2 1. 
1 min 
+I --- ----42min --------------__________________________-- 
t Potassium-free solution (7 mint 
+ IO-’ a/ml Norepineohrine 
t 5.0mM KCI 
Fig. 12. Potassium-induced relaxation of vascular smooth muscle. A helical strip of rat tail artery (previously denervated 
by acute treatment with B-hydroxydopamine) was made to contract by treatment with lo-’ g/ml norepinephrine in 
potassium-free solution. Two minutes later, 5 mM KCI was added, and a decrease in tension we8 observed. After a few 
minutes, an abrupt redevelopment of tension occurred. The relaxation in response to potessium is due to the electrogenic 
pumping of sodium end potassium by sodium-potassium ATPase. 
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the electrogenic pump is reduced leading to an 
accumulation of sodium intracellularly. When 
potassium is readmitted to the bath, the sodium 
pump is hyperactive because of the high intracel- 
lular concentration of sodium. Since the pump is 
electrogenic, membrane hyperpolarization oc- 
curs, and this event decreases membrane excit- 
ability and causes relaxation. Once the pump 
reduces the intracellular concentration toward 
normal, its activity decreases and the membrane 
potential returns to normal. The presence of 
norepinephrine then causes excitation of the cell 
and an abrupt increase in contractile tension is 
observed. The amplitude of potassium-induced 
relaxation is altered by experimental conditions 
that are known to affect the activity of sodium- 
potassium ATPase: (1) sodium concentra- 
tion;82-84 (2) potassium concentration;82-86 (3) 
magnesium concentration;82 (4) ouabain;66V82-88 
(5) temperature;82,x9 and (6) monovalent ion 
specificity.90s9’ 
Inhibition of pump activity by low temperature, 
potassium-free solution, and ouabain causes 
depolarization due to a reduced net rate of 
transfer of positive charge from the cells.94995 
Readmission of potassium after prolonged expo- 
sure to potassium-free solution results in a rapid 
membrane hyperpolarization, which is blocked 
by treatment with ouabain (Fig. 13). The magni- 
tude of the hyperpolarization is greater than the 
equilibrium potential for potassium, suggesting 
electrogenic transport. 
Ion Flux Measurement 
Transmembrane Electrical Potential 
Many observations about the electrogenic 
transport of sodium and potassium have been 
made using electrophysiologic techniques.92,93 
Sodium pump activity in isolated vascular 
smooth muscle has been investigated by analysis 
of ouabain-sensitive tissue uptake of radioactive 
potassium and efflux of radioactive sodium.67 
The ouabain-sensitive uptake of rubidium has 
also been used as an estimate of pump activity in 
vascular smooth muscle.97 Jones and cowork- 
ers67,97 have observed that the extracellular 
potassium concentration regulates both potas- 
sium uptake and sodium efflux, and that the 
half-concentration saturation of this regulatory 
effect is 2.5 mM potassium (see Fig. 14). Calcu- 
lation of the ratio of sodium efflux to potassium 
-101 ’ 
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Fig. 13. Effect of potassium-free solution and ouabain on the membrane potential. The membrane potential of vascular 
smooth muscle cells of the rabbit main pulmonary artery were measured using conventional microelectrode techniques. 
Exposure to potassium-free solution (indicated by the horizontal unbroken line) for 10 min depolarized the cell, after inducing 
e transient hyperpolarization. Readmission of potassium to the bathing medium hyperpolarized the cell (solid circles). The 
membrane potential returns to its resting value within 16 min after readmitting potassium. Treatment with ouabain (2 x 10-O 
M) depolarized the membrane and blocked the hyperpolarizing effect of potassium readmission (open circles). The chenges in 
membrane potential in mV are indicated by a “+” sign for depolarization and by a “-” sign for hyperpolarization. 
(Reproduced by permission of Journal of Physiology Rondon).“) 
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Fig. 14. Ouabain-sensitive ion fluxes in vascular 
smooth muscle. Ouabain-sensitive (10m4 MI radioactive 
sodium efflux (circles) and radioactive potassium influx 
(squares) into rabbit carotid artery at various extracellular 
concentrations of potassium were measured. The ratio of 
sodium to potassium flux is shown at the top (triangles). 
The arrows indicate the concentration of extracellular 
potassium required for half-saturation. (Reproduced by 
permission of the American Physiological Society!‘) 
influx at each extracellular concentration of 
potassium yielded a ratio of three sodium ions to 
two potassium ions, substantiating the electrog- 
enic character of the pump. 
Action Potential 
Most studies of action potentials in vascular 
smooth muscle have been performed on either 
the portal mesenteric vein or on the in situ 
terminal vascular bed.6’ There is a close tempo- 
ral relationship between the action potentials 
and the phasic contractile responses in these 
preparations.98 Although the action potentials 
are primitive and highly variable, interventions 
such as changes in electrolytes and neurohumo- 
ral agents in the environment initiate parallel 
changes in the mechanical responses.6’7g8 The 
propagation of action potentials occurs from 
cell-to-cell via low resistance tight junctions 
between the cells.’ 
The initiation of contraction without action 
potentials is a common observation in vascular 
smooth muscle. Electrophysiologic studies of the 
pulmonary artery,99 carotid artery,lw tail arte- 
ry, lo’ and other small arteries have indicated that 
action potentials are not associated with the 
contractile response. In some studies, the 
contractile response occurred without a change 
in resting membrane potentia1,‘00 whereas in 
other studies, the contraction in response to a 
vasoactive agonist was accompanied by a graded 
depolarization of the membrane.“’ Thus, it is 
clear that there are two different types of activa- 
tion mechanisms in vascular smooth muscle: (1) 
a type in which membrane excitation is coupled 
to the generation of action potentials, and (2) a 
type in which membrane excitation occurs with- 
out action potentials. In the latter case, the 
membrane excitation may be accompanied by a 
graded depolarization, but it is not evident if this 
is related to the contractile response, since 
increases in membrane permeability to monoval- 
ent ions also occur under these conditions. Addi- 
tionally, contraction and relaxation in response 
to specific agonists can occur in vascular smooth 
muscle placed in a depolarizing solution of 
potassium, which clamps the membrane poten- 
tial.98 
EXCITATION-CONTRACTION COUPLING 
Excitation-contraction coupling is the cellular 
process by which the excitatory events of the 
plasma membrane are linked to the interaction 
of the contractile proteins. Extensive evidence 
indicates that this coupling is the result of an 
increase in the cytoplasmic concentration of 
ionized calcium. When vascular smooth muscle 
is at rest, the intracellular concentration of 
ionized calcium is below 10m7 M.‘2*‘02*‘03 Maxi- 
mum contraction occurs at 10m5 M, relaxation 
occurs whenever the intracellular calcium 
concentration decreases over the range of 10m5 
M to lo-’ M. The concentration of activator 
calcium is determined by the sum of the net 
amounts delivered and sequestered by the 
membrane systems already described. From a 
functional point of view, there are four pools of 
calcium regulated by the three membrane 
systems: (1) an extracellular pool regulated by 
the permeability of the plasma membrane; (2) a 
cellular membrane or vesicular source; (3) a 
mitochondrial source; and (4) a sarcoplasmic 
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nation of specific enzyme activities suggest that 
the crude microsomal fractions isolated by these 
methods contain membrane fragments of sarco- 
plasmic reticulum and surface membrane, 
whereas the mitochondrial fraction consists of 
predominantly intact mitochondria. 
[co++] = ( a+ b+c+d) - (&b’+c’+d’) 
Fig. 15. Delivery and sequestration of calcium in exci- 
tation-contraction coupling. The concentration of activator 
calcium in the sarcoplasm is determined by the sum of the 
net amounts delivered and sequestered from four sources: 
(1 I extracellular space; 12) sarcoplasmic reticulum (SRk (31 
mitochondrie (MITI: and (4) plasma membrane or surface 
vesicles. DIeproduced by permission of John Wiley & 
Sons.m) 
The ability of subcellulat fractions of smooth 
muscle to actively sequester calcium is usually 
demonstrated by measuring the amount of 
radioactive calcium associated with membranes 
separated by filtration techniques. When cal- 
cium accumulation is performed in reaction 
mixtures containing the organic anion, oxalate, 
large amounts of calcium oxalate precipitates 
are formed within the subcellular structures.“’ 
In the absence of agents that precipitate calci- 
urn, intravesicular or intramitochondrial precipi- 
tation of calcium salts does not occur. In these 
experimental situations, the maximal levels of 
calcium accumulation are much lower and a 
steady state is readily achieved. 
reticular pool (Fig. 15). The contribution of 
activator calcium from each of these sources 
depends not only on the relative size of these 
pools but also on the mode of stimulation. Two 
major approaches have furnished evidence about 
the source of activator calcium in vascular 
smooth muscle: (1) cell fractionation studies and 
(2) studies employing agents that alter trans- 
membrane movement of calcium. 
Cell Fractionation Studies 
Many investigators, using a variety of vascu- 
lar tissues, have isolated subcellular fragments 
that are capable of actively sequestering calci- 
um.75,‘oc”4 The majority of these studies have 
used differential centrifugation of smooth mus- 
cle homogenates to isolate subcellular fractions 
that have been proposed to be potential sinks and 
sources of activator calcium. Mitochondria are 
isolated by sedimentation between 9500 and 
15,000 g and a microsomal fraction is obtained 
by centrifugation at 40,000-150,000 g. Purer 
fractions have been obtained with the aid of 
sucrose density gradients;‘14 and extraction of 
the microsomes in high ionic strength has been 
used to eliminate contamination by contractile 
proteins.” Morphological studies and determi- 
The requirements for calcium uptake by 
microsomal fractions from vascular smooth 
muscle appear to be similar to those for skeletal 
and cardiac muscle with both ATP and magne- 
sium ion being required for optimal activi- 
ty. ‘08~“‘~“3 Substitution of ATP with adenosine 
diphosphate (ADP) or other nucleoside triphos- 
phates (GTP, UTP, ITP, CTP) fails to sustain 
microsomal calcium uptake.“‘,“’ Microsomal 
calcium sequestration has also been shown to 
exhibit temperature and pH dependence. Cal- 
cium uptake is higher at 37°C than at 0% and 
intermediate temperatures; optimal pH values of 
7.4 and 7.8 have been reported.““*“3 
Calcium uptake by mitochondria isolated 
from vascular smooth muscle is not character- 
ized as well as microsomal calcium sequestra- 
tion. The uptake of calcium by the mitochondrial 
fraction is ATP and magnesium dependent, and 
it is usually observed to be somewhat greater 
than that in the microsomal fraction.“*“’ Many 
studies have shown that mitochondrial calcium 
sequestration is strongly inhibited by the meta- 
bolic inhibitor, sodium azide.75*‘09V”3 This effect 
is believed to be due to an inhibitory effect on 
mitochondrial ATPase. 
In addition to accumulating calcium, micro- 
somes and mitochondria isolated from vascular 
smooth muscle have been shown to release 
calcium after being preloaded.‘07*“‘~“6*“7 Bau- 
douin et al.“’ showed that half of the incorpo- 
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rated calcium in microsomes was released within 
1 min. These investigators also showed that the 
addition of ATP to the medium increased the 
rate of release. In contrast, Shibata and Hollan- 
der”’ and Zelck et a1.“6*“7 have shown that 
microsomes of vascular smooth muscle released 
approximately 20% of the calcium accumulated, 
and it was not dependent on the presence of 
ATP. Studies on microsomes of skeletal muscle 
have shown that calcium release is dependent on 
the presence of ADP and inorganic phos- 
phate.“83”9 This release is accompanied by the 
formation of ATP and is clearly demonstrated to 
be a reversal of the calcium pump. 
Studies Employing Agents That Alter 
Transmembrane Movement of Calcium 
The use of agents that effectively decrease 
transmembrane calcium movement has been a 
useful tool for studying the source of activator 
calcium in vascular smooth muscle. In general, 
selective suppression of calcium activation mech- 
anisms by these agents has identified two poten- 
tial sinks of calcium in vascular smooth muscle: 
(I) an extracellular and/or superficially bound 
fraction and (2) a more firmly bound and/or 
intracellular source. 
The basis for experiments utilizing calcium 
entry blockers is that depolarizing concentra- 
tions of potassium and norepinephrine, epineph- 
rine, angiotensin 11, and histamine differ in the 
way in which they mobilize calcium to elicit 
contraction of vascular smooth muscle. Contrac- 
tile responses induced by high concentrations of 
potassium decline rapidly in calcium-free 
medium, whereas those to norepinephrine, 
angiotensin II, epinephrine, and histamine 
persist with less reduction.65*‘2c’24 Similarly, the 
addition of calcium-chelating agents (EGTA) to 
calcium-free medium abolishes responses to 
potassium, but those to norepinephrine decline 
slowly. ‘22~‘23 Vascular smooth muscle incubated 
in a calcium-free potassium-depolarizing solu- 
tion can be made to contract by the addition of 
small concentrations of calcium. These contrac- 
tions are proportional to the calcium concentra- 
tion and are reversible. Epinephrine can also 
induce contraction of vascular smooth muscle in 
a calcium-free, potassium-depolarizing solution, 
but these responses are only about one-third of 
the contractile tension developed in calcium- 
containing medium. I25 Godfraind and Kaba’25*‘26 
showed that cinnarizine inhibits the contractile 
response to calcium of depolarized muscle, 
whereas it had no effect on epinephrine-induced 
contraction of mesenteric artery in calcium-free 
depolarizing solution. SKF-525A has been 
shown to block potassium-induced contractions 
of rabbit aorta’*’ and verapamil antagonizes the 
calcium-induced contractions of depolarized 
rabbit main pulmonary artery.99 Responses of 
these vessels to norepinephrine were inhibited 
only after long exposure to high concentrations 
of the calcium entry blockers. Similarly, 
lanthanum has a greater inhibitory effect on 
potassium-induced contractions of rabbit aortic 
smooth muscle than on responses elicited by 
norepinephrine.‘24*‘2* These observations suggest 
that potassium initiates contractions by promot- 
ing the movement of extracellular and/or super- 
ficially bound calcium to the contractile 
elements, but does not directly interfere with 
mobilization of calcium by norepinephrine from 
a separate more firmly bound source. The effects 
of SKF-525A and lanthanum on responses to 
histamine and angiotensin II indicate that these 
stimulants utilize superficial and firmly bound 
calcium to differing extents in producing 
contraction of vascular smooth muscle.‘273’28 
Both agents appear to activate contraction by 
mobilization of intracellular calcium, but 
histamine also appears to mobilize calcium from 
the superficially bound sources. 
Van Breemen et a1.‘243’29*‘30 have demonstrated 
that lanthanum blocks the passage of radioactive 
calcium across the cell membrane of vascular 
smooth muscle, while displacing superficially 
bound and extracellular calcium. By measuring 
the amount of radioactive calcium remaining in 
vascular strips after lanthanum treatment, these 
investigators have shown that increases in 
tension produced by potassium are paraheled by 
an elevation in intracellular calcium content. 
Norepinephrine, which also causes an increase 
in tension, produced no increase in intracellular 
calcium concentration. These results, again, 
indicate that contraction induced by potassium 
is dependent on extracellular sources of calcium 
whereas norepinephrine-induced contracture is 
dependent on intracellular pools of calcium. 
These generalizations about the mechanisms 
of contraction in response to potassium and nore- 
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pinephrine are by no means absolute. For 
instance, recent observations by van Breemen 
and Siege113’ suggest that norepinephrine- 
induced contractions in dog coronary arteries are 
determined only by the influx of extracellular 
calcium across the cell membrane. Apparently, 
this artery does not contain an intracellular pool 
of calcium that is sensitive to the alpha-adrener- 
gic agonist. Allen and coworkers’32*‘33 have 
described similar evidence for an extracellular 
calcium source in dog basilar artery contracted 
with phenylephrine or serotonin. In arteries such 
as these, the membrane channels opened by 
norepinephrine appear to differ from those 
opened by potassium, since contractions pro- 
duced by potassium are 10 times more sensitive 
to the calcium entry blockers, D-600 and SKF- 
525A, than those produced by norepinephrine.13’ 
Recent studies in myocardial tissue have 
formed the basis for a model whereby the glyco- 
calyx (a coating external to the unit membrane) 
participates in the control of transmembrane 
ionic exchange.‘34 The glycocalyx is composed of 
two layers: (1) an inner, less dense component 
(20 nm thick) and (2) an outer, slightly more 
dense component (30 nm thick). The inner coat 
is often referred to as the surface coat and the 
outer layer as the external lamina. The glycoca- 
Fig. 16. Schematic representation of the unit mem- 
brane and glycocalyx. Closed circles represent hydrophilic 
polar heads of lipid molecules at either side of the unit 
membrane. The irregular structures within the unit 
membrane are integral proteins with negatively cherged 
oligosaccharide chains extending into the surface coat of 
the glycocalyx. Other negatively charged oligosaccharide 
chains are present in the external lamina. The negatively 
charged layer at the unit membrane surface coat interface 
is due in part to phospholipids. (Reproduced by permission 
of American hurn8i of Physiology.‘y) 
lyx has a high concentration of negatively 
charged sites of which sialic acid residues are a 
large component. These residues are terminal 
groups in the oligosaccharide portions of the 
glycoproteins and glycolipids composing the 
glycocalyx. The sialic acid residues of the inner 
surface coat are derived from integral proteins 
embedded in the lipid bilayer of the cell 
membrane (see Fig. 16). Treatment of myocar- 
dial tissue with neuraminidase, which selectively 
removes sialic acid residues, increases the uptake 
and washout of radioactive calcium approxi- 
mately fivefold. Additionally, following neuram- 
inidase treatment, lanthanum ion, which is 
normally restricted to the extracellular space, 
enters the cell and displaces more than 80% of 
the exchangeable calcium. These investigators 
proposed that the glycocalyx may be necessary 
for the prevention of uncontrolled entry of acti- 
vator calcium into the cell. In vascular smooth 
muscle, contractile responses to norepinephrine 
or methoxamine are potentiated following treat- 
ment with neuraminidase (Fig. 17). The mecha- 












Fig. 17. Neuraminidase treatment and contractile 
responses to norepinephrine. Helical strips of rat tail artery 
were made to contract in response to the cumulative 
addition of norepinephrine before and after treatment with 
neuraminidase (0.2 U/ml in calcium-free physiologic salt 
solution for 60 min). Following treatment with neuramini- 
dase. contractile responses to ell concentretions of norepi- 
nephrine were greater than control responses. The aster- 
isks indicate a statistically signigcant difference between 
neuraminidese-treated strips and control strips @ < 0.061. 
The values indicate the mean f standard error of the mean 
for 5 rets Urom Rice end Webb, unpublished observations, 
by permission.) 
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related to a mechanism similar to that proposed 
for myocardial cells. 
Sodium ions may play an important role in 
cell membrane transfer of calcium ions (sodium- 
calcium exchange).13’ Replacement of external 
sodium with lithium, choline, or sucrose causes 
reversible contractions of vascular smooth 
muscle.‘36’3g Reuter et al.“” have observed that 
these contractions are associated with a net gain 
of calcium by the tissue. The mechanism of this 
exchange process is believed to be a countertran- 
sport “carrier” process whereby one calcium ion 
is extruded and three sodium ions are accumu- 
lated by the cell. The electrochemical gradient 
for sodium ion is the driving force for mainte- 
nance of intracellular calcium in this model. 
CYCLIC NUCLEOTIDES AND THE CONTROL OF 
INTRACELLULAR CALCIUM 
Current observations suggest that the cyclic 
nucleotides may be intimately involved in the 
molecular events that link contraction and relax- 
ation to the release and uptake of activator 
calcium by subcellular fractions. In general it is 
accepted that cyclic adenosine 3’S’-monophos- 
phate (cyclic AMP) functions in the events that 
lead to relaxation of smooth muscle, whereas 
cyclic guanosine 3’S’-monophosphate (cyclic 
GMP) may participate in both the regulation of 
contraction and relaxation.‘U 
Cyclic AMP 
Several observations indicate that the vasodi- 
lator effect of beta-adrenergic agonists, as well 
as phosphodiesterase inhibitors, is mediated by 
cyclic AMP. Beta-adrenergic stimulants induce 
relaxation of vascular smooth muscle and they 
also cause an elevation in cyclic AMP 
levels.‘04*‘05*‘4’-‘46 Studies by AnderssonlW and 
Collins and Sutter14’ have demonstrated a 
temporal and quantitative correlation between 
the elevation of cyclic AMP levels and the relax- 
ing effect of isoproterenol (Fig. 18). The genera- 
tion of cyclic AMP, induced by isoproterenol, 
can be reduced by beta-adrenergic blocking 
agents.14’ Some investigators have reported that 
beta-adrenergic stimulants can also activate 
adenylate cyclase activity from vascular smooth 
muscle in cell-free systems.‘48~‘4g However, early 
work on homogenates of rabbit and dog arteries 
indicated that adenylate cyclase activity was not 
e 
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Fig. 18. Temporal relationship between cyclic AMP 
content and relaxation induced by iroproterenol. Rabbit 
anterior menenteric-portal veins were contracted by addi- 
tion of 30 mM KCI in the presence of lo-’ M phentolamine. 
Relaxation was induced by addition of 6 x lo-” M isopro- 
tersnol. There was a temporal correlation between the 
elevation in cyclic AMP levels and the relaxing effect of 
isoproterenol. Each point represents the mean obtained 
from 4 veins. (Reproduced by permission of Canadian 
Journal of Physiology and Pharm8coiogy.‘w ) 
activated by beta-adrenergic agonists.‘42*‘50,‘5’ 
Triner et al.14’ and Namm and Leader’52 suggest 
that homogenization of the tissue may destroy 
hormonal sensitivity or produce endogenous 
inhibitors of adenylate cyclase and therefore 
account for these inconsistencies. Relaxation in 
response to beta-adrenergic agonists has been 
shown to be potentiated by agents that inhibit 
phosphodiesterase and there is an increase in the 
level of cyclic AMP.‘42 Cyclic AMP itself or its 
dibutytyl derivative will produce vascular relax- 
ation 104~142~147~153~156 
Many investigators have examined the possi- 
bility that cyclic AMP mediates relaxation 
through the regulation of intracellular calci- 
um.‘04~‘05*‘47~‘57-‘6’ Incubation of vascular smooth 
muscle microsomes with cyclic AMP enhances 
energy-dependent calcium sequestra- 
tion. ‘04~‘05~‘47*‘57-‘6’ Studies on nonvascular 
smooth muscle’04*‘05*‘47*‘62-‘69 and striated mus- 
cle’7k’79 have yielded similar results. Calcium 
uptake by vascular smooth muscle microsomes 
has been reported to be stimulated 39%~49% by 
cyclic AMP. These responses are concentration- 
dependent with approximately 5-10 PM cyclic 
AMP yielding the maximal response. It there- 
fore appears that cyclic AMP may mediate 
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relaxation by increasing calcium sequestration 
by the microsomes. 
Little information is available about the 
mechanism by which cyclic AMP increases 
calcium sequestration in vascular smooth mus- 
cle, but it may be similar in nature to that which 
has been proposed for the heart (Fig. 19). It is 
now well accepted that cyclic AMP exerts its 
effect through the activation of cyclic-AMP- 
dependent protein kinase.‘*0~‘8’ Cyclic AMP acti- 
vates the enzyme by combining with the regula- 
tory subunit, thereby causing its dissociation 
from the catalytic subunit of the enzyme (Fig. 
19). The activated enzyme then catalyzes the 
transfer of the gamma-phosphate of ATP to 
protein substrates that participate in calcium 
transport. 
Few studies have been performed in vascular 
smooth muscle that attempt to link the role of 
cyclic-AMP-dependent protein kinase phospho- 
rylation with calcium metabolism. Alexander et 
al.‘** found that microsomes prepared from the 
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intimal-medial layers of rabbit aorta contained 
intrinsic protein kinase activity. This enzyme 
phosphorylated both endogenous and exogenous 
(histone) substrates. In the presence of cyclic 
AMP, the kinase activity was stimulated 
twofold. These microsomes were also shown to 
exhibit calcium uptake activity, and cyclic AMP 
increased the activity by 13%. Bhalla et al.ls9 
have observed that cyclic-AMP-dependent pro- 
tein kinase augmented the phosphorylation of 
serine residues in an aortic microsomal protein 
component with a molecular weight of about 
44,000 daltons. Intrinsic phosphoprotein phos- 
phatase cleaved the labeled phosphate from the 
cyclic AMP-stimulated microsomes. Aortic mi- 
crosomes phosphorylated in the presence of 
cyclic AMP or cyclic AMP plus protein kinase 
exhibited enhanced calcium uptake. Fitzpatrick 
and Szentivanyi’(” have also observed that cyclic 
AMP plus protein kinase augments calcium 
transport in rabbit aortic microsomes. These 
studies suggest that membrane phosphorylation- 





ADENYLATE CYCLASE ACTIVATION 
Fig. 19. Cyclic AMP and 
the control of intracellular cal- 
cium. Beta-adrenergic agonists 
induce rebxation of vascular 
smooth muscle and they also 
cause an elevation in cyclic 
AMP levels. Cyclic AMP exerts 
ita effect through the activa- 
tion of cyclic AMP-dependent 
protein kinase (R, regulatory 
subunit and C, catalytic sub- 
unit). The catalytic subunit of 
this enzyme transfers the gam- 
ma-phosphate of ATP to pro- 
tein rubstretes that perticipte 
in calcium transport. (Repro- 
duced by permission of Else- 
vier/North Hollend.+DD) 
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dephosphorylation may play a role in regulating 
calcium translocation in vascular smooth mus- 
cle. However, some investigators’83 have re- 
ported that cyclic AMP does not alter microso- 
ma1 calcium transport. 
Cyclic GMP 
The evidence implicating a role for cyclic 
GMP in the relaxation or contraction of vascular 
smooth muscle is unclear. Studies by Dunham et 
al.lg4 indicated that prostaglandin-induced con- 
tracton of bovine and canine veins was accom- 
panied by an increase in cyclic GMP, with no 
consistent qualitative change in cyclic AMP 
concentrations. Thus, it was postulated that 
cyclic AMP and cyclic GMP may play opposing 
roles in regulating the tone of smooth muscle 
(Yin-Yang hypothesis). However, recent studies 
suggest that this hypothesis is much too simpli- 
fied. 
Schultz and others’85-‘88 have observed that an 
increase in cyclic GMP levels in smooth muscle 
might be secondary to an altered calcium ion 
concentration. These investigators observed that 
segments of rat ductus deferens incubated in 
calcium-free medium had lower levels of cyclic 
GMP as compared to control. Treatment of the 
tissue with acetylcholine, norepinephrine, or 
high potassium in calcium-free medium did not 
increase cyclic GMP levels. However, when 
these agents were tested in a calcium-containing 
medium, cyclic GMP increased threefold. Simi- 
lar studies on guinea pig intestinal smooth 
muscle’85 have also shown that acetylcholine, 
histamine, serotonin, and potassium were able to 
stimulate cyclic GMP levels only in the presence 
of calcium. In canine femoral artery,lg9 phenyl- 
ephrine produces contraction but does not alter 
cyclic GMP levels, whereas carbachol and 
methacholine elevate cyclic GMP levels but do 
not cause contraction. Similarly, prostaglandins 
initiate contraction of human umbilical arteries 
but have no effect on cyclic GMP levels.“’ 
Exogenous application of cyclic GMP to 
vascular preparations has also yielded informa- 
tion that implies that cyclic GMP may not be 
involved in contraction. Cohen and Berkowitz’53 
observed that cyclic GMP applied to isolated 
aortic strips results in relaxation. Schultz 
observed that the 8-bromo derivative of cyclic 
GMP, but not dibutyryl cyclic GMP, inhibited 
agonist-induced contractions of rat aorta.“’ 
Schultz and coworkers’86*‘88 have proposed 
that cyclic GMP is involved in the relaxation of 
vascular smooth muscle. Vasodilators such as 
nitroprusside and nitroglycerin increase the level 
of cyclic GMP in vascular smooth muscle up to 
50-fold.‘92 It is obvious that the role of cyclic 
GMP in contraction and relaxation of vascular 
smooth muscle requires further investigation. 
ENERGY METABOLISM AND HYPOXIA 
As in most cells, the utilizable form of chemi- 
cal energy in vascular smooth muscle is that 
derived from the cleavage of inorganic phos- 
phate from ATP. In relation to the function of 
vascular smooth muscle, it is important to deter- 
mine if cellular processes involved in the produc- 
tion of ATP act as rate-limiting factors for 
contraction and relaxation. 
There is evidence that vascular smooth muscle 
contains the enzymatic machinery for the 
synthesis of ATP from any of the potential 
fuels-carbohydrates, lipids, and proteins.35 The 
substrate utilization pattern of these three physi- 
ologic energy sources is unclear. Glucose uptake 
by vascular smooth muscle has been reported to 
be either greater than or less than that needed to 
support respiration and glycolysis.‘93*‘94 Gly- 
cogen may serve as an alternative energy source 
during rapid transients in contractile ATP 
requirements,‘95 however, it is not depleted 
during prolonged exposure to substrate-free 
media.‘96*‘97 Fatty acids are taken up by vascular 
smooth muscle, and the rate at which they are 
oxidized suggests that they may be utilized as a 
steady-state energy source.‘98 Exogenous amino 
acids slightly increase or maintain respiration in 
vascular smooth muscle.‘99 The rate of ATP 
synthesis in vascular smooth muscle is approxi- 
mately 0.5-2.0 mole/g-min, which is very simi- 
lar to that of skeletal muscle under resting condi- 
tions, 0.3-2.2 mole/g-min.3s 
The regulation of energy metabolism in vascu- 
lar smooth muscle is mainly determined by the 
products of ATP hydrolysis-ADP and inor- 
ganic phosphate3’,*@’ (see Fig. 20). If excess ADP 
accumulates and it is hydrolyzed to 5’-AMP, this 
nucleotide will accelerate the production of 
glucose-l-phosphate. Calcium ion also has a 
regulatory role in that it catalyzes the action of 
phosphorylase kinase. 
Impaired oxygen delivery to the tissues results 
in vascular smooth muscle relaxation and 
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Fig. 20. Regulatory systems that stimulate ATP 
production and perallel increase in ATP utilixation. The 
ADP and inorganic phosphate that result from ATP hydrol- 
ysis stimulate both glycolytic and oxidative ATP production 
(indicated by the circled “1”). The #-AMP that accumu- 
lates following excessive ADP production stimulates the 
phosphoryfating action of phosphorylssa b (circled “2”). 
Calcium released in excitation-contraction coupling 
increases the activity of phosphorylase kinasa. (Repro- 
duced by permission of John Wiley & Sons.m) 
conversely increased oxygen delivery results in 
constriction of resistance vessels. These effects 
are important determinants of active and passive 
hyperemia and may play a role in autoregulation 
of blood flow. It is not clear how much of these 
vascular smooth muscle responses are due 
directly to a change in the energy source or 
alternately to a change in the concentration of 
vasodilation tissue metabolites. Early observa- 
tions203 indicated that the magnitude of contrac- 
tion of smooth muscle of the rabbit aorta was a 
function of the po, over a physiologic range (see 
Fig. 21). This relation was thought to support 
the possibility that contraction of vascular 
smooth muscle was immediately dependent on 
po, for its energy supply and that this constituted 
a mechanism for active and reactive hyperemia. 
Subsequently, Pittman and Duling204 presented 
/ 
convincing evidence against this direct effect of 
po, on vascular smooth muscle contraction, 
suggesting that the primary regulation was 
effected by tissue metabolites. Now in a recent 
study, Detar205 observed that the hypoxic depres- 
sion of vascular smooth muscle contraction is 
eliminated by G. strophanthin or in a muscle 
bath in which lithium had been substituted for 
sodium (see Fig. 22). These observations indi- 
cate that this depression may result from 
hypoxic stimulation of the electrogenic pump 
and consequent membrane hyperpolarization. 
SUMMARY 
The goal of this survey was to review briefly 
the molecular mechanisms that regulate vascu- 
lar smooth muscle function. Components of the 
machinery involved in the contraction and relax- 
ation of vascular smooth muscle include the 
following. 
Contractile proteins. The force generated 
by vascular smooth muscle is the result of thin 
(actin) and thick (myosin) filaments being 
pulled by one another so that the cell tends to 
shorten. The processes by which this intereaction 
is regulated are a matter of some debate. Howev- 
er, most observations indicate that the process 
that initiates contraction is a calcium-dependent 
phosphorylation of the myosin light chain. 
Cellular sites for the regulation of myoplas- 
mic calcium concentration. The final event 
that initiates the contractile process is an 
increase in the intracellular concentration of 
ionized calcium. Cellular sites that may contrib- 
ute to the raising and lowering of ionized 




PO2 hmHg) ’ 7o < 50 
100 
Fig. 21. Relationship of pal to contractile tension developed by rabbit aorta strip in response to epinephrine. Specific 
oxygen tensions are indicated by numbers on the po, tracing. The parallelism between smooth muscle tension and pch of the 
muscle bath suggest that contractile activity is directly dependent on bath ps. (Reproduced by permission of American 
Journal of Physiofogy.wl 
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Fig. 22. Effects of G-strophanthin (lo-’ ML substitution of LiCl for NaCI, and reduced temperature on the relationship 
between pq and tension development in response to norepinephrine of strips from small coronary or skeletal muscle arteries 
of the rabbi. Numbers in parentheses indicate number of samples tested. All three test conditions inhibited the 
hypoxia-induced depression. Since all three conditions also inhibit the sodium-potassium APTare responsible for the 
electrogenic pump, these results suggest that hypoxic inhibition of contraction may reflect a stimulation of the sodium- 
potassium ATPase. (Reproduced by permission of American Journal of Physiobgy.=) 
brane, (B) sarcoplasmic reticulum, and (C) 
mitochondria. 
Membrane electrical events. The electrical 
state of the cell membrane influences contractile 
responses of vascular smooth muscle. Over the 
physiologic range, an elevation in the membrane 
potential has a reciprocal influence on muscle 
excitability. The membrane potential is the sum 
of the diffusion potentials and the electrogenic 
pump. 
Excitation-contraction coupling. The exci- 
tatory events of the cell membrane (changes in 
membrane potential and the generation of action 
potentials) are coupled to the interaction of the 
contractile proteins by an increase in myoplas- 
mic ionized calcium. 
Cyclic nucleotides and calcium. Cyclic 
AMP and cyclic GMP may link contraction and 
relaxation to the release and uptake of activator 
calcium by subcellular organelles. These nucleo- 
tides also influence the level of phosphorylation 
of the myosin light chain. 
Energy metabolism and hypoxia. The 
chemical energy source for cellular processes in 
vascular smooth muscle is ATP. Vascular tone, 
or maintenance of a contractile force, in this 
muscle is a relatively efficient process that may 
reflect a special noncycling link between myosin 
and actin. Current evidence suggests that 
hypoxic conditions influence vascular tone by 
altering the activity of the electrogenic sodium 
pump. 
This listing of statements is by no means the 
final word in molecular mechanisms that govern 
vascular tone. Indeed, vascular smooth muscle 
remains to be a constant source of surprises for 
the interested investigator. 
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